LegisTrack
Back to all bills
HR 4492119th CongressIn Committee

Don’t Sell My DNA Act

Introduced: Jul 17, 2025
Sponsor: Rep. Cline, Ben [R-VA-6] (R-Virginia)
Technology & Innovation
Standard Summary
Comprehensive overview in 1-2 paragraphs

The Don’t Sell My DNA Act (H.R. 4492) would amend title 11 of the U.S. Code (bankruptcy law) to add genetic information to the category of protected information inside bankruptcy estates. The bill uses the Genetic Information Nondiscrimination Act (GINA) definition of genetic information. It would restrict how genetic data in a bankruptcy estate can be used, sold, or leased, require affirmative written consent from all affected individuals (including non-parties) before any such use or sale, require advance notice to those whose genetic information would be affected, and require deletion of any genetic data from the estate that is not subject to disposition, using court-approved deletion methods. The changes would take effect upon enactment and apply to cases pending, commenced, or reopened after enactment. In short, the bill strengthens privacy protections around genetic information in bankruptcy proceedings, making it harder to monetize or disclose DNA data and mandating recovery or deletion of genetic data that isn’t disposed of through a sale or lease.

Key Points

  • 1Adds genetic information to the list of protected property in bankruptcy by amending §101(41A)(A), defining it per GINA (42 U.S.C. 2000ff).
  • 2Limits use, sale, or lease of personally identifiable genetic information in a bankruptcy proceeding: such actions require affirmative written consent from all affected persons after the case starts; sale is not allowed if it would violate applicable nonbankruptcy law.
  • 3Establishes a new notice requirement in §363: any use, sale, or lease of genetic information must be preceded by actual written notice to every person whose genetic information would be affected.
  • 4Adds a deletion obligation in §1107(c): a trustee or debtor in possession must delete genetic information from the estate that was not disposed of, using court-approved methods (potentially including NIST’s sanitization guidelines, SP 800-88).
  • 5Effective date and scope: applies on enactment and to cases pending as of enactment or commenced/reopened after enactment.

Impact Areas

Primary: Individuals whose genetic information is in a bankruptcy estate (including non-parties whose data is involved) — privacy protections and consent requirements apply to the handling, sale, or use of their genetic data.Secondary: Bankruptcy trustees and debtors in possession — new duties to obtain consent, provide notice, and ensure deletion of undisposed genetic data; potential compliance and administrative burdens.Additional impacts: Potential effects on creditors and the overall administration of bankruptcy estates (costs, timelines, and risk of disputes over consent or notice); interaction with existing privacy and data-security laws; potential rise in data-sanitization costs and procedures to ensure data is properly removed.
Generated by gpt-5-nano on Oct 8, 2025